PolyNovo Expands to 8 Balkan Countries via Distribution Deal Covering 22M People
PolyNovo is a pioneering medical technology company that specializes in developing innovative synthetic skin substitutes and medical devices using their patented NovoSorb® bioabsorbable polymer technology. As an ASX 200 listed company, they are focused on transforming wound care and medical treatment by creating advanced biomaterials that enable natural healing and improve patient outcomes.
The company’s core technology, NovoSorb®, represents a breakthrough in medical device design, offering biodegradable solutions that simplify the management of acute and complex wounds. Their products are designed to provide a sophisticated alternative to traditional wound treatment methods, with a strong emphasis on patient-centric care and advanced technological innovation. PolyNovo is committed to reimagining the standard of care by developing medical solutions that support the body’s natural healing processes.
Globally recognized and operating across multiple markets including Australia, the United States, United Kingdom, and Ireland, PolyNovo is dedicated to advancing medical technology. Their mission goes beyond creating medical devices; they aim to fundamentally transform how complex wounds are treated, putting patients’ needs and natural healing capabilities at the forefront of their technological development. By focusing on cutting-edge biomaterials and a patient-first approach, PolyNovo is positioning itself as a disruptive force in the medical technology landscape.
© 2026 StockWire X Pty Ltd. All rights reserved.
Join +20,000 subscribers receiving alerts.
Join thousands of investors who rely on StockWire X for timely, accurate market intelligence.
StockWire X delivers fast, reliable, and actionable insights into significant developments across global markets, with coverage spanning technology, biotechnology, healthcare, financials, and emerging industries. Our mission is to provide clear, data-driven content that empowers investors to identify opportunities and make informed decisions ahead of the market.
Our network spans key financial and investment hubs worldwide, ensuring subscribers receive timely updates on market-moving announcements, news, macroeconomic trends, and corporate developments.
Use of Technology
We harness advanced technologies to enhance the speed, accuracy, and relevance of our reporting.
While technology accelerates our workflow, every piece of content is selected, validated, and published by human professionals, in accordance with best practices for accuracy, transparency, and investor value. This hybrid approach ensures speed without compromising editorial integrity.
Feedback and Accuracy
We are committed to accuracy and fairness in our reporting. If you believe any information we have published is inaccurate, incomplete, or misleading, please contact us at admin@stockwirex.com so we can review and address the matter promptly.
StockWire X provides readers with access to market news, educational content, and commentary from financial services professionals, industry experts, and companies (“Contributors”).
StockWire X does not hold an Australian Financial Services Licence (AFSL) and relies on the exemption available under section 911A(2)(eb) of the Corporations Act 2001 (Cth) in respect of any financial product advice provided.
Any advice or information published by StockWire X is general in nature only and has been prepared without taking into account your personal objectives, financial situation, or needs. Before acting on any information, you should consider whether it is appropriate for your circumstances and seek independent, licensed financial advice. You should also obtain and read any relevant Product Disclosure Statement (PDS) or other offer document before making an investment decision.
StockWire X makes no guarantee as to the accuracy, completeness, or timeliness of the information provided, and accepts no responsibility for any loss arising from reliance on it. All content is published in good faith for informational purposes only.
StockWire X may have commercial relationships with some contributors or companies mentioned in our content. Any such relationships will be disclosed where relevant.
If you believe any information we have published is inaccurate, incomplete, or misleading, please contact us at admin@stockwirex.com so we can review and address the matter promptly.